You are subscribed to the Managed Healthcare Executive eNews
eNewsletter Subscribe
Print/Digital Subscribe
February 27, 2015
Web Version | Digital Edition | Share with a colleague
Like Tweet
Public and private insurers are seizing the opportunity to devise programs that promote preventive care and positive behaviors. » Details
A pilot program between Independence Blue Cross and engagement firm Accolade is producing real-world results for members. » Learn how
The prostate cancer drug leuprolide acetate (Lupron Depot), used in conjunction with acetylcholinesterase inhibitor (AChEI), slowed memory loss in female Alzheimer's patients, according to a study. » Results
IN CASE YOU MISSED IT
• Retailers, insurers and providers chase new healthcare opportunities
• Attracting and retaining talent for a new model
• Move over Sovaldi: Could PCSK9 inhibitors be a bigger cost challenge?
We value your input. Please send your comments and article ideas to lisa.smith@advanstar.com.
Editorial Questions? Contact the Editorial Team. Click Here. Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.